Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Fontana

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|July 29, 2010
Approaches to the study of drug-induced liver injuryR J Fontana
Digestive Diseases (Basel, Switzerland)|March 30, 2001
Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis CR J Fontana
Digestive Diseases and Sciences|May 2, 2001
Uric acid nephrolithiasis associated with interferon and ribavirin treatment of hepatitis CR J Fontana
Current Opinion in Gastroenterology|October 7, 2006
Acute liver failureR J Fontana
Gastroenterology Clinics of North America|December 1, 1995
Genetic predisposition to drug-induced liver diseaseR J Fontana, P B Watkins
The American Journal of Gastroenterology|October 1, 1996
Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective reviewR J Fontana, J L Barnett
Journal of Viral Hepatitis|May 8, 2013
IL-28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta-analysisA S Rangnekar, R J Fontana
Journal of Hepatology|August 22, 2000
Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?R J Fontana, A S Lok
Alimentary Pharmacology & Therapeutics|January 20, 2012
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosisA K Singal, R J Fontana
Alimentary Pharmacology & Therapeutics|May 6, 2015
Editorial: hepatocellular carcinoma--a rare complication of hepatic venous outflow tract obstructionN D Parikh, R J Fontana
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|July 29, 2010
Approaches to the study of drug-induced liver injuryR J Fontana
Digestive Diseases (Basel, Switzerland)|March 30, 2001
Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis CR J Fontana
Digestive Diseases and Sciences|May 2, 2001
Uric acid nephrolithiasis associated with interferon and ribavirin treatment of hepatitis CR J Fontana
Current Opinion in Gastroenterology|October 7, 2006
Acute liver failureR J Fontana
Gastroenterology Clinics of North America|December 1, 1995
Genetic predisposition to drug-induced liver diseaseR J Fontana, P B Watkins
The American Journal of Gastroenterology|October 1, 1996
Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective reviewR J Fontana, J L Barnett
Journal of Viral Hepatitis|May 8, 2013
IL-28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta-analysisA S Rangnekar, R J Fontana
Journal of Hepatology|August 22, 2000
Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?R J Fontana, A S Lok
Alimentary Pharmacology & Therapeutics|January 20, 2012
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosisA K Singal, R J Fontana
Alimentary Pharmacology & Therapeutics|May 6, 2015
Editorial: hepatocellular carcinoma--a rare complication of hepatic venous outflow tract obstructionN D Parikh, R J Fontana
Pageof 6